Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen Mangar

Showing results (11-20 of 31) with videos related to

Pageof 4
Sort By:
Healthcare (Basel, Switzerland)|May 28, 2022
Evaluating Patterns and Factors Related to Sleep Disturbances in Prostate Cancer PatientsShalini Mondal, Steve Edwards, Erik Wibowo, et al.
EJNMMI Research|June 10, 2015
Preliminary clinical assessment of the relationship between tumor alphavbeta3 integrin and perfusion in patients studied with [(18)F]fluciclatide kinetics and [ (15)O]H 2O PETLaura M Kenny, Giampaolo Tomasi, Federico Turkheimer, et al.
Plos One|March 20, 2024
Childhood experiences and sleep problems: A cross-sectional study on the indirect relationship mediated by stress, resilience and anxietyRola Ashour, Elizabeth J Halstead, Stephen Mangar, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 27, 2022
Eligibility for <sup>177</sup>Lu-PSMA Therapy Depends on the Choice of Companion Diagnostic Tracer: A Comparison of <sup>68</sup>Ga-PSMA-11 and <sup>99m</sup>Tc-MIP-1404 in Metastatic Castration-Resistant Prostate CancerGary J R Cook, Wai-Lup Wong, Bal Sanghera, et al.
Nuclear Medicine Communications|November 9, 2013
Exploring the potential of [11C]choline-PET/CT as a novel imaging biomarker for predicting early treatment response in prostate cancerAmarnath Challapalli, Tara Barwick, Giampaolo Tomasi, et al.
Biosensors & Bioelectronics|April 16, 2025
Handheld ISFET Lab-on-Chip detection of YAP1 nucleic acid and AR-FL and AR-V7 mRNA from liquid biopsies for prostate cancer prognosisJoseph Broomfield, Melpomeni Kalofonou, Costanza Gulli, et al.
European Urology Open Science|January 3, 2022
A Systematic Review of Patients' Values, Preferences, and Expectations for the Treatment of Metastatic Prostate CancerMartin J Connor, Mesfin G Genie, David Burns, et al.
Physics in Medicine and Biology|May 11, 2012
Imaging of cellular proliferation in liver metastasis by [18F]fluorothymidine positron emission tomography: effect of therapyKaiyumars Contractor, Amarnath Challapalli, Giampaolo Tomasi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 1, 2011
Use of [11C]choline PET-CT as a noninvasive method for detecting pelvic lymph node status from prostate cancer and relationship with choline kinase expressionKaiyumars Contractor, Amarnath Challapalli, Tara Barwick, et al.
BJU International|July 31, 2025
Preferences between three options for androgen deprivation therapy: a focus group studyHannah L Rush, Sophie Merrick, John Marshall, et al.
Pageof 4

Showing results (11-20 of 31) with videos related to

Sort By:
Pageof 4
Healthcare (Basel, Switzerland)|May 28, 2022
Evaluating Patterns and Factors Related to Sleep Disturbances in Prostate Cancer PatientsShalini Mondal, Steve Edwards, Erik Wibowo, et al.
EJNMMI Research|June 10, 2015
Preliminary clinical assessment of the relationship between tumor alphavbeta3 integrin and perfusion in patients studied with [(18)F]fluciclatide kinetics and [ (15)O]H 2O PETLaura M Kenny, Giampaolo Tomasi, Federico Turkheimer, et al.
Plos One|March 20, 2024
Childhood experiences and sleep problems: A cross-sectional study on the indirect relationship mediated by stress, resilience and anxietyRola Ashour, Elizabeth J Halstead, Stephen Mangar, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 27, 2022
Eligibility for <sup>177</sup>Lu-PSMA Therapy Depends on the Choice of Companion Diagnostic Tracer: A Comparison of <sup>68</sup>Ga-PSMA-11 and <sup>99m</sup>Tc-MIP-1404 in Metastatic Castration-Resistant Prostate CancerGary J R Cook, Wai-Lup Wong, Bal Sanghera, et al.
Nuclear Medicine Communications|November 9, 2013
Exploring the potential of [11C]choline-PET/CT as a novel imaging biomarker for predicting early treatment response in prostate cancerAmarnath Challapalli, Tara Barwick, Giampaolo Tomasi, et al.
Biosensors & Bioelectronics|April 16, 2025
Handheld ISFET Lab-on-Chip detection of YAP1 nucleic acid and AR-FL and AR-V7 mRNA from liquid biopsies for prostate cancer prognosisJoseph Broomfield, Melpomeni Kalofonou, Costanza Gulli, et al.
European Urology Open Science|January 3, 2022
A Systematic Review of Patients' Values, Preferences, and Expectations for the Treatment of Metastatic Prostate CancerMartin J Connor, Mesfin G Genie, David Burns, et al.
Physics in Medicine and Biology|May 11, 2012
Imaging of cellular proliferation in liver metastasis by [18F]fluorothymidine positron emission tomography: effect of therapyKaiyumars Contractor, Amarnath Challapalli, Giampaolo Tomasi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 1, 2011
Use of [11C]choline PET-CT as a noninvasive method for detecting pelvic lymph node status from prostate cancer and relationship with choline kinase expressionKaiyumars Contractor, Amarnath Challapalli, Tara Barwick, et al.
BJU International|July 31, 2025
Preferences between three options for androgen deprivation therapy: a focus group studyHannah L Rush, Sophie Merrick, John Marshall, et al.
Pageof 4